Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2022-08-03 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document is an RNS announcement from PureTech Health PLC dated August 3, 2022. The title explicitly states 'Transaction in Own Shares' and the content details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of a company reporting the purchase or sale of its own shares. Reviewing the filing definitions: - 10-K/AR/IR: Not a full annual or interim financial report. - ER/MDA: Not an earnings release or management discussion. - DIRS: This is about the company buying shares, not directors' personal dealings. - The most fitting category is 'Transaction in Own Shares' (Code: POS), which covers share repurchase/issuance activity.
2022-08-03 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from PureTech Health PLC dated August 2, 2022. The title explicitly states 'Transaction in Own Shares' and details the purchase of 60,600 ordinary shares as part of a 'Share Buyback Programme'. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS).
2022-08-02 English
Akili/Shionogi Begin Ph3 ADHD Study in Japan
Regulatory Filings Classification · 95% confidence The document is a press release issued via RNS (RNS Number: 3510U) on August 1, 2022, by PureTech Health PLC. The content details an operational update regarding its Founded Entity, Akili, announcing the start of a pivotal Phase 3 clinical study for a digital treatment (SDT-001) in Japan, conducted by partner Shionogi. This is not a formal financial report (like 10-K or IR), nor is it a proxy statement (DEF 14A) or an earnings release (ER). It is a general corporate announcement regarding clinical trial progress and partnership activities. Since it is a regulatory news service (RNS) announcement that doesn't fit the more specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), the most appropriate classification is the general Regulatory Filings category, which often serves as the catch-all for significant, non-standard corporate news released via regulatory feeds.
2022-08-01 English
Transaction in Own Shares
Transaction in Own Shares Classification · 98% confidence The document is an RNS announcement from PureTech Health PLC, dated August 1, 2022, detailing 'Transaction in Own Shares'. It explicitly states that the company purchased shares as part of its 'Share Buyback Programme' and provides detailed transaction logs (volume, price, date). This activity directly corresponds to the definition of 'Transaction in Own Shares', which maps to the filing type code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). Although it is an RNS announcement, the content is highly specific to share repurchase activity, making POS the most accurate classification over the general RNS fallback.
2022-08-01 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title: "PureTech Health PLC ... Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (28 July 2022), including volume, high, low, and VWAP prices. This directly corresponds to the definition of a Transaction in Own Shares (Share Repurchase/Issuance). This matches filing type code POS.
2022-07-29 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (27 July 2022), including volume, high, low, and VWAP prices. This directly corresponds to the definition of a company reporting the purchase or sale of its own shares. This matches Filing Type Code POS (Transaction in Own Shares).
2022-07-28 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.